Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015‐2018

Background Clinical surveillance of the prevalence of contact allergy in consecutively patch tested patients is a proven instrument to continually assess the importance of contact allergens (haptens) assembled in a baseline series. Objectives To present current results from the European Surveillance...

Full description

Saved in:
Bibliographic Details
Published in:Contact dermatitis Vol. 84; no. 2; pp. 109 - 120
Main Authors: Uter, Wolfgang, Bauer, Andrea, Belloni Fortina, Anna, Bircher, Andreas J., Brans, Richard, Buhl, Timo, Cooper, Susan M., Czarnecka‐Operacz, Magdalena, Dickel, Heinrich, Dugonik, Aleksandra, Geier, Johannes, Giménez‐Arnau, Ana M., Gonçalo, Margarida, Johansen, Jeanne D., Johnston, Graham A., Mahler, Vera, Rustemeyer, Thomas, Sanchez‐Perez, Javier, Schuttelaar, Marie L.A., Simon, Dagmar, Spiewak, Radoslaw, Valiukevičienė, Skaidra, Weisshaar, Elke, White, Ian R., Wilkinson, Mark, Aberer, Werner, Ballmer‐Weber, Barbara, Becker, Detlef, Beiteke, Ulrike, Brasch, Jochen, Chowdhury, Mahbub M., Corradin, Maria Teresa, Dietrich, Cecilia, Gallo, Rosella, Grabbe, Jürgen, John, Swen Malte, Pandurovic, Maja Kalac, Kecelj, Nada, Kmecl, Tanja, Kränke, Birger, Filon, Francesca Larese, Lunder, Tomaž, Mercader, Pedro, Navarini, Alexander, Peserico, Andrea, Pesonen, Maria, Ruiz, Inmaculada, Sadowska‐Przytocka, Anna, Scherer‐Hofmeier, Kathrin, Schliemann, Sibylle, Godnič, Mojca Simončič, Stingeni, Luca, Stone, Natalie, Vok, Marko, Wagner, Nicola, Werfel, Thomas
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01.02.2021
Wiley Subscription Services, Inc
Subjects:
Allergens
Allergies
clinical epidemiology
contact allergy
Haptens
Heavy metals
Nickel
patch testing
Preservatives
Quality control
RRID:SCR_001905
Surveillance
contact allergy
surveillance
RRID:SCR_001905
patch testing
clinical epidemiology
ISSN:0105-1873, 1600-0536, 1600-0536
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Clinical surveillance of the prevalence of contact allergy in consecutively patch tested patients is a proven instrument to continually assess the importance of contact allergens (haptens) assembled in a baseline series. Objectives To present current results from the European Surveillance System on Contact Allergies, including 13 countries represented by 1 to 11 departments. Methods Anonymized or pseudonymized patch test and clinical data from various data capture systems used locally or nationally as transferred to the Erlangen data centre were pooled and descriptively analysed after quality control. Results In the 4 years (2015‐2018), data from 51 914 patients patch tested with the European baseline series (EBS) of contact allergens were analysed. Contact allergy to nickel was most frequent (17.6% positive), followed by contact allergy to fragrance mix I (6.9%), methylisothiazolinone (MI; 6.2%), and Myroxylon pereirae resin (balsam of Peru; 5.8%). Conclusions While the prevalence of MI contact allergy decreased substantially following regulatory intervention, the persistently high levels of allergy to metals, fragrances, other preservatives, and rubber chemicals point to problems needing further research and, potentially, preventive efforts. Results with national additions to the baseline series provide important information on substances possibly to be considered for inclusion in the EBS.
Bibliography:Funding information
Collaborators: ESSCA working group: Werner Aberer, Department of Dermatology, Medical University of Graz, Graz, Austria; Barbara Ballmer‐Weber, Department of Dermatology, University Hospital Zürich and Clinic of Dermatology and Allergology, Kantonsspital St. Gallen, Zürich, Switzerland; Detlef Becker, Department of Dermatology, University of Mainz, Mainz, Germany; Ulrike Beiteke, Department of Dermatology, Dortmund, Germany; Jochen Brasch, Department of Dermatology, University of Schleswig‐Holstein, Campus Kiel, Kiel, Germany; Mahbub M. Chowdhury, Welsh Institute of Dermatology, Cardiff, UK; Maria Teresa Corradin, Dermatology Unit, Santa Maria degli Angeli Hospital, Pordenone, Italy; Cecilia Dietrich, Department of Dermatology, University of Schleswig‐Holstein, Campus Kiel, Kiel, Germany; Rosella Gallo, Clinica Dermatologica, IRCCS – AOU San Martino – IST and Department of Health Sciences, University of Genoa, Genoa, Italy; Jürgen Grabbe, Department of Dermatology, Kantonsspital Aarau, Aarau, Switzerland; Swen Malte John, Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm), University of Osnabrück, Lower Saxony Institute for Occupational Dermatology (NIB), Osnabrück, Germany; Maja Kalac Pandurovic, Outpatient Clinic of Dermatology, Maribor, Maribor, Slovenia; Nada Kecelj, Outpatient Clinic of Dermatology, Ljubljana, Slovenia; Tanja Kmecl, Department of Dermatology, General Hospital Celje, Celje, Slovenia; Birger Kränke, Department of Dermatology, Medical University of Graz, Graz, Austria; Francesca Larese Filon, Department of Public Health, Occupational Medicine, University of Trieste, Trieste, Italy; Tomaž Lunder, Department of Dermatology, University Medical Center, Ljubljana, Slovenia; Pedro Mercader, Dermatology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain; Alexander Navarini, Department of Dermatology, University Hospital Zürich, Zürich, Switzerland; Andrea Peserico, Department of Dermatology, University of Padova, Padova, Italy; Maria Pesonen, Occupational Medicine, Finnish Institute of Occupational Health (FIOH), Helsinki, Finland; Inmaculada Ruiz, Department of Dermatology, Complejo Asistencial de León, León, Spain; Anna Sadowska‐Przytocka, Department of Dermatology, Poznań University of Medical Sciences, Poznań, Poland; Kathrin Scherer‐Hofmeier, Allergy Unit, Dept. of Dermatology, University Hospital Basel, Basel, Switzerland; Sibylle Schliemann, Department of Dermatology and Allergology, University Hospital Jena, Jena, Germany; Mojca Simončič Godnič, Department of Dermatology, Novo Mesto, Slovenia; Luca Stingeni, Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy; Natalie Stone, Aneurin Bevin Health Board, Newport, Gwent, UK; Marko Vok, Outpatient Clinic of Dermatology, Izola, Slovenia; Nicola Wagner, Department of Dermatology, University of Erlangen‐Nürnberg, Erlangen, Germany; Thomas Werfel, Medizinische Hochschule Hannover, Department of Immunodermatology and Experimental Allergy, Hannover, Germany.
Partial funding by EADV Grant PPRC‐2018‐8
Funding Information: Partial funding by EADV Grant PPRC‐2018‐8.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0105-1873
1600-0536
1600-0536
DOI:10.1111/cod.13704